BetaGlue Therapeutics
Entity

  • BetaGlue Therapeutics

  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,231 1,231

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    20121 Milan, Metropolitan City of Milan, Italy

    Milan

    Italy

  • Employees

    Scale: 11-50

    Estimated: 16

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    9 months, 2 weeks ago
Description
  • Value proposition

    Precision Radiotherapy From Within

    BetaGlue Therapeutics is a clinical stage oncology company that has developed an advanced radiotherapy platform enabling localised targeted treatment of both unresectable solid tumours and also treatment of surgical resection margins called YntraDose.

    radiotherapy, nuclear medicine, oncology, and medical devices

  • Home - BetaGlue

    BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.

    • https://betaglue.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics